The People Who Drive BioFabUSA

See ARMI|BioFabUSA’s dedicated Leadership Team, Board of Directors, Stakeholder Council and Leadership Advisory Council.

Leadership

DEAN KAMEN

Executive Director & Chairman of the Board

Maureen Toohey

Deputy Executive Director & Secretary of the Board

Jennifer Macdonald

M.D. Chief Operating Officer, ARMI

Jim Scott
Chief Administrative Officer
Thomas Bollenbach

Ph.D., Chief Technology Officer

Richard McFarland

Ph.D., M.D., Chief Regulatory Officer

Stefany Shaheen

Chief Strategy Officer

Julie Lenzer

Chief Innovation Officer

Karla Talanian

Chief Education & Workforce Officer

Ned Gordon

Chief Operating Officer, BioFabUSA

Board of Directors

Like-minded people—who are from different spheres but have changed the world in their own ways—make up ARMI’s board of directors.

DEAN KAMEN

ARMI Executive Director, DEKA CEO, serial inventor and FIRST founder

Martine Rothblatt

United Therapeutics CEO and Sirius Satellite Radio founder

John Abele

Boston Scientific founder and medical device pioneer

Dr. Jim Weinstein

Senior Vice President for Microsoft Healthcare, and former CEO of Dartmouth-Hitchcock

Blake Moret

Rockwell Automation CEO and veterans and workforce-development champion

Stakeholder Council

The Stakeholder Council consists of the ARMI board of directors and key personnel from the U.S. Department of Defense.

Dawn Rosarius,  U.S. Army Medical Research & Development Command

Dr. Kate Sixt,  Office of the Secretary of Defense

Kathleen Berst, Defense Health Agency

Dr. Lloyd Rose,  U.S. Army Medical Materiel Development Activity

Tracy Frost,  Office of the Secretary of Defense

 

 

 

Leadership Advisory Council

The Leadership Advisory Council (LAC) provides industry expertise and strategic guidance to the stakeholder council. Members of the council are elected by BioFabUSA’s membership. The Technical Advisory Subcommittee (TASC) works to organize and provide technical input from BioFabUSA members. This group comprised of six individuals from the LAC.

Amy Peterson, University of Massachusetts, Lowell

Andrew Lee, Fluidform

Anna Gosiewska, Celularity

Caralynn Nowinski Collens, Dimension Inx

Carina Clingman, Recruitomics

Cato Laurencin, University of Connecticut

Dave Lewandowski, Azenta Life Sciences

Eric Schuur, HepaTx

Esther Latres, Juvenile Diabetes Research Foundation

Gagan Naeger, Rockwell Automation

George Christ, University of Virginia

George Pins, Worcester Polytechnic Institute

Jan Jensen, Trailhead Bio

Jian Ling, Southwest Research Institute

Katie Zander, Standards Coordinating Body, TASC

Lisa Larkin, Skeletal Tissue Engineering Laboratory

Marcie Black, Advanced Silicon Group

Maria Pascale, MPR Associates

Marian McCord, University of New Hampshire

Mark Powers, ThermoFisher Scientific

Michael Golway, Advanced Solutions Life Sciences, TASC

Orchid Garcia, J&J, TASC

Paul Goodwin, Cytiva

Priya Baraniak, OrganaBio, TASC

Sarindr “Ik” Bhumiratana, Epibone

Shivaram Selvam, Georgia Tech, TASC

Stu Jacobson, DEKA, TASC

Tim Bertram, ProKidney

BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

Technology

ARMI

Initiatives

Learn more about work underway to build the biofabrication ecosystem and accelerate the science of regenerative medicine.